Navigation Links
Savara Pharmaceuticals Appoints Two New Members to Its Board of Directors
Date:12/5/2013

AUSTIN, Texas, Dec. 5, 2013 /PRNewswire/ -- Savara Pharmaceuticals announced today that the company has appointed Dr. Joseph S. McCracken, DVM and Yuri Pikover to its Board of Directors.

Dr. McCracken has more than 25 years of experience in technical, business development and market development roles with biotechnology and pharmaceutical companies. Most recently he was Global Head of Business Development & Licensing at Roche Pharmaceuticals where he was responsible for Roche's global in-licensing and out-licensing activities. Prior to joining Roche, Dr. McCracken held the position of Vice President of Business Development at Genentech for more than a decade.

Mr. Pikover is a Managing Director of 37 Technology Ventures, a boutique venture fund focusing on growing startups, and currently serves on the boards of numerous companies. From 1993 to 2008, he founded and held executive roles at Xylan, Access360, 5square and Folsom Lake Nissan, and served on the boards of several dozen companies. Prior to 1993, Yuri held technical and management positions with Micom Systems and Fibermux Corporation.

"We are delighted to welcome Joseph and Yuri to our Board of Directors at an exciting time for the company," said Rob Neville, CEO, Savara Pharmaceuticals. "The two bring a breadth of business development and public company experience to our team that will help achieve our long term growth objectives."

Last April, Savara Pharmaceuticals announced the initiation of a Phase 2 clinical trial evaluating the safety and efficacy of AeroVanc for the treatment of persistent methicillin-resistant Staphylococcus aureus (MRSA) lung infection in cystic fibrosis (CF) patients. AeroVanc is the first inhaled antibiotic being developed to address the growing population of MRSA lung-infected CF patients.

Abo
'/>"/>

SOURCE Savara Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
2. Savara Pharmaceuticals AeroVanc Granted U.S. Orphan Drug Designation for the Treatment of MRSA Lung Infection in Cystic Fibrosis Patients
3. Savara Pharmaceuticals Announces Formation of Clinical Advisory Board
4. Tech Coast Angels Contributes More Than $3 Million to $16 Million Savara Pharmaceuticals Series B
5. Savara Pharmaceuticals Initiates Phase 2 Clinical Trial of AeroVanc for MRSA Lung Infection in Cystic Fibrosis Patients
6. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... SEATTLE , BERKELEY, Kalifornien, und KOPENHAGEN, ... CMC Biologics, Inc. , ein Weltmarktführer der ... und anderen therapeutischen Proteinen, gab heute bekannt, ... Expansionsstrategie der Produktionskapazität den Ausbau der nordamerikanischen ... , mit der Ergänzung  einer Einweg-Anlage Bioreactor ...
(Date:6/30/2015)... June 30, 2015  EnteroMedics Inc. (NASDAQ: ETRM ... neuroblocking technology to treat obesity, metabolic diseases, and other ... public offering  of 40,229,886 units. Each unit consists of ... A warrant to purchase one share of common stock, ... one share of common stock, at a purchase price ...
(Date:6/30/2015)... 2015  Egalet Corporation (Nasdaq: EGLT ... company focused on developing, manufacturing and marketing ... from a Category 3 human abuse liability ... oral oxycodone product candidate in late-stage clinical ... enough to require daily, around-the-clock opioid treatment ...
Breaking Medicine Technology:CMC Biologics baut GMP-Produktionskapazität in den USA aus 2CMC Biologics baut GMP-Produktionskapazität in den USA aus 3EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 4Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 5
... YONKERS, N.Y., Sept. 27, 2011 As a result ... that could be dangerous to their health, according to ... Americans who currently take a prescription medicine told pollsters ... a doctor,s visit or medical procedure, declining tests, or ...
... Pa., Sept. 27, 2011 Inovio Pharmaceuticals, Inc. (NYSE ... development of synthetic immunogens against cancers and infectious diseases, ... Research and Development Agreement (CRADA) with the United States ... Plum Island Animal Disease Center. This collaboration will evaluate ...
Cached Medicine Technology:Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 2Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 3Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 4Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 5Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines' Potential to Help Ensure Nation's Food Supply Safety 2Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines' Potential to Help Ensure Nation's Food Supply Safety 3Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines' Potential to Help Ensure Nation's Food Supply Safety 4
(Date:6/30/2015)... ... June 30, 2015 , ... Dr. Sammy Masri of Masri Sports Medicine ... specializes in the diagnosis and treatment of non-surgical sports and other musculoskeletal injuries for ... in recreational athletics and use exercise to stay healthy and active. Dr. Masri seeks ...
(Date:6/30/2015)... ... June 30, 2015 , ... MJH Associates ... HRA Healthcare Research & Analytics , a consultative healthcare market research practice that ... of businesses. HRA offers quantitative and qualitative, custom and multi-client primary market research ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... are partnering to improve access to cancer prevention, screening and care for the ... have announced an affiliation that will see Roswell Park faculty providing clinical consultations ...
(Date:6/30/2015)... NY (PRWEB) , ... June 30, 2015 , ... New ... New York July 7th and 11th 2015. Timber frame post and beam raisings offer ... , “Raising a timber frame is an important and exciting event ...
(Date:6/30/2015)... ... June 30, 2015 , ... LifeAID Beverage Company has ... leading organizations dedicated to raising worldwide awareness of the burgeoning “adaptive” movement, I ... now the official charity of FitAID. I AM ADAPTIVE is a non-profit whose ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 2Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 3Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 4Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 5Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 2Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 4Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 5Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 2Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 3Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 4Health News:LifeAID Beverage Company Partners With The Adaptive Movement 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 3
... of a fatty acid known as docosahexaenoic acid (DHA) ... //of developing dementia and Alzheimer’s disease, according to a ... have all been found to increase the risk of ... 70 percent of cases of dementia in the elderly, ...
... A research article published in the Lancet has brought to ... for the Indian //community. With only 2.2percent of the Adult ... clearly shows that the Indian body constitution is responsible. ... population in India between the age groups of 30 and ...
... flu can trigger a potentially debilitating neurological disorder called ... although they do stress that these findings should not ... ,Lead author of the study by the Institute ... "It is very, very small," referring to the risk ...
... Prescription sleep aids may do little to improve the ... with obstructive sleep apnea (OSA). A new study published ... of the American College of Chest Physicians (ACCP), finds ... aids were no more likely to use their CPAP ...
... as weight-loss surgery, obesity surgery and gastric-bypass surgery. In- ... problems. The mortality rate as per records is 2 ... ratings company, conducted a study on bariatric surgery complication ... differ in hospitals in accordance with their ratings. ...
... heat and humidity that lead to dehydration can signal a ... week at the American// College of Rheumatology Annual Scientific Meeting ... monosodium uric crystals, causes severe pain and swelling of the ... period of a few days, most often the big toe, ...
Cached Medicine News:Health News:Higher Level of Certain Fatty Acid Associated with Lower Dementia Risk 2Health News:Rare Neurological Disorder Linked to Flu shot 2Health News:Research Questions Use of Sleep Meds for Patients with Apnea 2Health News:Complications Resulting From Bariatric Surgery Vary With HealthGrades Ratings 2Health News:Complications Resulting From Bariatric Surgery Vary With HealthGrades Ratings 3Health News:It's the Heat and the Humidity: How Each Worsens Gout Symptoms 2
... Integra II SP MRI-Compatible Anesthesia System is perfect ... more than one type of anesthetic agent. ... and due to its wider stance, has a ... ventilator bellows assembly is utilized in both the ...
... Market leader in soft tissue repair in ... has developed the latest evolution in orthopedic ... ORTHOCORD Suture is as strong as any ... importantly, ORTHOCORD Suture handles like ETHIBOND®., ,ORTHOCORD ...
... PURPLE NITRILE* product family offers a comprehensive ... gloves were designed as an alternative for ... hypersensitivity to natural rubber latex proteins. The ... from latex and other synthetic gloves. Custom ...
... and the distinctive COLOR PURPLE* distinguish ... them for sterile clinical procedures when ... required. Theyre designed as an alternative ... Type 1 hypersensitivity to natural rubber ...
Medicine Products: